Profiel
Jun Liu is currently Deputy General Manager-Equities at Changjiang Securities (Shanghai) Asset Management Co., Ltd. since 2016.
Former positions include Analyst at Changjiang Securities Co., Ltd. (Broker) and Member-Supervisory Board at Shanghai Junshi Biosciences Co., Ltd. from 2019 to 2021.
Education includes an undergraduate degree conferred in 2000 and a graduate degree conferred in 2006, both from Tongji University.
Actieve functies van Jun Liu
| Bedrijven | Functie | Begin |
|---|---|---|
Changjiang Securities (Shanghai) Asset Management Co., Ltd.
Changjiang Securities (Shanghai) Asset Management Co., Ltd. Investment ManagersFinance Changjiang AM is an active, risk-aware manager which invests in equity and fixed-income across market-caps and sectors aiming to achieve above-average returns and preserve capital. | Head-Equity Investments | 01-05-2016 |
Eerdere bekende functies van Jun Liu
| Bedrijven | Functie | Einde |
|---|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Directeur/Bestuurslid | 29-06-2021 |
Changjiang Securities Co., Ltd. (Broker)
Changjiang Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Opleiding van Jun Liu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Tongji University
Tongji University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Changjiang Securities Co., Ltd. (Broker)
Changjiang Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Changjiang Securities (Shanghai) Asset Management Co., Ltd.
Changjiang Securities (Shanghai) Asset Management Co., Ltd. Investment ManagersFinance Changjiang AM is an active, risk-aware manager which invests in equity and fixed-income across market-caps and sectors aiming to achieve above-average returns and preserve capital. | Finance |
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Junshi Biosciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures monoclonal antibody drugs | Health Technology |
















